Literature DB >> 17156743

Multilayers at the surface of solutions of exogenous lung surfactant: direct observation by neutron reflection.

D Follows1, F Tiberg, R K Thomas, M Larsson.   

Abstract

Pharmacy-grade exogenous lung surfactant preparations of bovine and porcine origin, dispersed in physiological electrolyte solution have been studied. The organization and dynamics at the air/water interface at physiological temperature was analysed by neutron reflection. The results show that a well-defined surface phase is formed, consisting of a multilayer structure of lipid/protein bilayers alternating with aqueous layers, with a repetition period of about 70 A and correlation depths of 3 to >25 bilayers, depending on electrolyte composition and time. The experimental surfactant concentration of 0.15% (w/w) is far below that used in therapeutic application of exogenous surfactants and it is therefore likely that similar multilayer structures are also formed at the alveolar surface in the clinical situation during surfactant substitution therapy. Lung surfactant preparations in dry form swell in aqueous solution towards a limit of about 60% (w/w) of water, forming a lamellar liquid-crystalline phase above about 34 degrees C, which disperses into lamellar bodies at higher water concentrations. The lamellar spacings in the surface multilayers at the air/water interface are smaller than those in the saturated limit even though they are in contact with much greater water concentrations. The surface multilayers are laterally disordered in a way that is consistent with fragments of Lalpha-phase lamellae. The near surface layers of the multilayer structure have a significant protein content (only SP-B and SP-C are present in the preparations). The results demonstrate that a multilayer structure can be formed in exogenous surfactant even at very low concentrations and indicate that multilayers need to be incorporated into present interpretations of in vitro studies of similar lung surfactant preparations, which are largely based on monolayer models.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17156743     DOI: 10.1016/j.bbamem.2006.10.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  The biophysical function of pulmonary surfactant.

Authors:  Sandra Rugonyi; Samares C Biswas; Stephen B Hall
Journal:  Respir Physiol Neurobiol       Date:  2008-07-16       Impact factor: 1.931

Review 2.  Interfacial assembly of proteins and peptides: recent examples studied by neutron reflection.

Authors:  XiuBo Zhao; Fang Pan; Jian R Lu
Journal:  J R Soc Interface       Date:  2009-08-05       Impact factor: 4.118

3.  Effect of cholesterol on the molecular structure and transitions in a clinical-grade lung surfactant extract.

Authors:  Jenny Marie Andersson; Carl Grey; Marcus Larsson; Tiago Mendes Ferreira; Emma Sparr
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

4.  Tensiometric and Phase Domain Behavior of Lung Surfactant on Mucus-like Viscoelastic Hydrogels.

Authors:  Daniel M Schenck; Jennifer Fiegel
Journal:  ACS Appl Mater Interfaces       Date:  2016-03-01       Impact factor: 9.229

5.  Lipid polymorphism induced by surfactant peptide SP-B(1-25).

Authors:  R Suzanne Farver; Frank D Mills; Vijay C Antharam; Janetricks N Chebukati; Gail E Fanucci; Joanna R Long
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

6.  Structure of SP-B/DPPC mixed films studied by neutron reflectometry.

Authors:  W K Fullagar; S A Holt; I R Gentle
Journal:  Biophys J       Date:  2008-08-15       Impact factor: 4.033

7.  Competitive adsorption: a physical model for lung surfactant inactivation.

Authors:  Jonathan G Fernsler; Joseph A Zasadzinski
Journal:  Langmuir       Date:  2009-07-21       Impact factor: 3.882

8.  Effects of hydrophobic surfactant proteins on collapse of pulmonary surfactant monolayers.

Authors:  Florence Lhert; Wenfei Yan; Samares C Biswas; Stephen B Hall
Journal:  Biophys J       Date:  2007-08-24       Impact factor: 4.033

9.  Suppression of Lα/Lβ Phase Coexistence in the Lipids of Pulmonary Surfactant.

Authors:  Jonathan R Fritz; Ryan W Loney; Stephen B Hall; Stephanie Tristram-Nagle
Journal:  Biophys J       Date:  2020-12-19       Impact factor: 4.033

Review 10.  Interactions of particulate matter and pulmonary surfactant: Implications for human health.

Authors:  Feifei Wang; Jifang Liu; Hongbo Zeng
Journal:  Adv Colloid Interface Sci       Date:  2020-08-19       Impact factor: 12.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.